Hyperbranched Ketone Thioglycol Polyethylene Glycol Acrylate (HBPAK)

Hyperbranched Ketone Thioglycol Polyethylene Glycol Acrylate (HBPAK)

Catalog Number:
BP01578683AME
Mfr. No.:
AM-BIOWAY0003
Price:
Quantity:
Add to Cart:
    • Overview
      • Hyperbranched ketithiolide polyethylene glycol acrylate (HBPAK) is a hyperbranched polymer obtained through a Michael addition reaction between ketithiolide diamine (TK) and polyethylene glycol diacrylate (PEGDA). This material not only inherits the reactive oxygen species (ROS) responsiveness of ketithiolides, but its unique hyperbranched topology also endows it with functions such as a crosslinking agent and drug carrier. In biomedical applications, HBPAK is commonly used as a structural component of hydrogels or microgels to scavenge excess ROS generated after tissue damage, thereby reducing inflammation and providing a new material option for the treatment of diseases such as myocardial infarction and stroke. The ketithiolide diamine units abundant in the HBPAK structure can specifically respond to reactive oxygen species (ROS) in the skin microenvironment, achieving intelligent release or structural reconstruction, precisely targeting oxidative stress areas. With polyethylene glycol as its backbone, it possesses excellent water solubility and biocompatibility; its hyperbranched structure endows it with high capacity for loading active substances and stability.
        • One-step reaction synthesis, mild process, no toxic byproducts, and controllable purity of raw materials.

        Please contact us at for specific academic pricing.

    • Properties
      • Categories
        Biomedical Polymers
        CAS Number
        3025991-86-7
        Appearance
        Solid powder
        Purity
        >95%
    • Applications
      • Application Description
        This material is suitable for developing new raw materials with antioxidant and anti-inflammatory effects, slowing down collagen and lipid damage, delaying skin aging, and improving skin tolerance. Based on this material, a linear ROS-responsive, biodegradable unsaturated polyurethane was obtained, leading to the successful development of a multifunctional elastomer myocardial patch. This patch rapidly consumes ROS, reduces cardiomyocyte apoptosis, increases the M2/M1 macrophage phenotype ratio, and lowers the expression level of inflammatory factors. After implantation, it helps maintain similar cardiac function, ventricular size, wall thickness, and vascular maturity in infarcted hearts as in the sham-operated group.